Published in Br Med J on January 02, 1971
Endoscopic injection of adrenaline for actively bleeding ulcers: a randomised trial. Br Med J (Clin Res Ed) (1988) 1.97
Survey of management in acute upper gastrointestinal haemorrhage. J R Soc Med (1980) 1.52
Neodymium yttrium aluminium garnet laser photocoagulation for major haemorrhage from peptic ulcers and single vessels: a single blind controlled study. Br Med J (Clin Res Ed) (1983) 1.39
Heat probe thermocoagulation and pure alcohol injection in massive peptic ulcer haemorrhage: a prospective, randomised controlled trial. Gut (1990) 1.13
Why portal hypertensive varices bleed and bleed: a hypothesis. Gut (1995) 1.10
The management of upper gastrointestinal hemorrhage: a multiparametric computer analysis. Ann Surg (1974) 0.98
Bleeding peptic ulcer--risk factors for rebleeding and sequential changes in endoscopic findings. Gut (1994) 0.97
Clinical courses and predictors for rebleeding in patients with peptic ulcers and non-bleeding visible vessels: a prospective study. Gut (1994) 0.96
Surgical management of bleeding chronic peptic ulcer. A 10-year prospective study. Ann Surg (1984) 0.75
Criteria for selective admission of patients with haematemesis. J R Soc Med (1992) 0.75
Clarifying the relationship between ABO/Rhesus blood group antigens and upper gastrointestinal bleeding. Dig Dis Sci (2008) 0.75
Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J (1970) 4.31
Hematemesis and melena; with special reference to causation and to the factors influencing the mortality from bleeding peptic ulcers. Gastroenterology (1956) 3.64
ABO blood group and secretor status in relation to clinical characteristics of peptic ulcers. Gut (1965) 2.11
The pH Stability of Viruses of Newcastle Disease and Fowl Plague. Science (1947) 2.05
Haematemesis, with special reference to peptic ulcer. Br Med J (1955) 1.89
Central venous pressure in clinical management of acute gastrointestinal bleeding. Lancet (1970) 1.88
The loss and replacement of red cells in patients with acute gastrointestinal haemorrhage. Q J Med (1958) 1.47
Blood volumes in gastroduodenal haemorrhage. Lancet (1956) 1.31
Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet (1992) 6.28
Risk assessment after acute upper gastrointestinal haemorrhage. Gut (1996) 5.02
Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet (1995) 5.02
Helicobacter pylori infection. Lancet (1997) 4.58
Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet (1996) 4.55
C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ (1996) 3.61
Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. Lancet (1994) 3.45
Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J (1994) 3.13
Cimetidine in duodenal ulcer. Controlled trial. Lancet (1976) 3.08
Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart (1997) 2.50
Controlled trial of argon laser photocoagulation in bleeding peptic ulcers. Lancet (1981) 2.36
Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet (1986) 2.23
Fibrinogen: a link between chronic infection and coronary heart disease. Lancet (1994) 2.19
Endoscopic prediction of recurrent bleeding in peptic ulcers. N Engl J Med (1981) 2.19
Helicobacter pylori infection in childhood: risk factors and effect on growth. BMJ (1994) 2.15
Increased risk of cancer at multiple sites after gastric surgery for peptic ulcer. Gut (1987) 2.08
Prevention by bedtime cimetidine of duodenal-ulcer relapse. Lancet (1978) 2.03
Variation in outcome after acute upper gastrointestinal haemorrhage. The National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet (1995) 2.03
Central venous pressure in clinical management of acute gastrointestinal bleeding. Lancet (1970) 1.88
Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum. Gut (1995) 1.72
Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect (1995) 1.69
Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestine. Gut (1973) 1.64
Gall-bladder sensitivity to cholecystokinin in patients with gall stones. Br Med J (1980) 1.64
Controlled trial of Nd-YAG laser photocoagulation in bleeding peptic ulcers. Lancet (1986) 1.62
Biological effects of intrahepatic neodymium:yttrium-aluminum-garnet laser photocoagulation in rats. Gastroenterology (1987) 1.54
Gastric emptying and secretion of bile acids, cholesterol, and pancreatic enzymes during digestion. Duodenal perfusion studies in healthy subjects. Mayo Clin Proc (1974) 1.53
Nature of the bleeding vessel in recurrently bleeding gastric ulcers. Gastroenterology (1986) 1.50
Controlled trial of cimetidine in acute upper gastrointestinal bleeding. Br Med J (1979) 1.48
Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy. Eur J Gastroenterol Hepatol (1997) 1.42
Postprandial gall-bladder emptying in patients with gall stones. Br Med J (1980) 1.41
Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects. Gut (1975) 1.41
Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects. Gut (1995) 1.39
Biliary lipid secretion in gallstone patients. Lancet (1973) 1.39
Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut (1995) 1.36
Oxygen therapy for spontaneous pneumothorax. Br Med J (1971) 1.33
Bedtime cimetidine maintenance treatment: optimum dose and effect on subsequent natural history of duodenal ulcer. Gut (1982) 1.33
Emergency arteriography in acute gastrointestinal bleeding. Br Med J (1976) 1.25
Effect of cimetidine in symptomatic gastro-oesophageal reflux. Lancet (1978) 1.24
Gallstone recurrence after medical dissolution. An overestimated threat? J Hepatol (1986) 1.22
Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients. Gastroenterology (1975) 1.16
Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication. Gastroenterology (1992) 1.14
Cardiac complications of phaeochromocytoma. Br Heart J (1967) 1.14
Optimal timing of doses of chenic acid in patients with gall stones. Br Med J (1979) 1.14
Value of small intestinal bile acid analysis in the diagnosis of the stagnant loop syndrome. Gut (1973) 1.08
Argon laser photocoagulation in bleeding peptic ulcers. Lancet (1982) 1.08
Postprandial gallbladder motor function: refilling and turnover of bile in health and in cholelithiasis. Gastroenterology (1995) 1.06
Surface hydrophobicity of gastric mucosa in peptic ulcer disease. Relationship to gastritis and Campylobacter pylori infection. Gastroenterology (1990) 1.05
Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration. Gastroenterology (1996) 1.04
Five years' experience of a gastroenterology day-case unit. Lancet (1983) 1.03
Transmission of Helicobacter pylori infection. Gut (1995) 1.03
Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid. Br Med J (Clin Res Ed) (1981) 1.02
The effects of unsaturated fatty acids on Helicobacter pylori in vitro. J Med Microbiol (1995) 1.02
Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis. Gut (1984) 1.01
A randomized trial of endoscopy vs no endoscopy in the management of seronegative Helicobacter pylori dyspepsia. Eur J Gastroenterol Hepatol (1998) 1.01
Bile salt metabolism in the normal human small intestine. Gut (1970) 0.99
Carcinoma of the gastric stump: risks and pathogenesis. Gut (1990) 0.99
Review article: faecal markers in the assessment of activity in inflammatory bowel disease. Aliment Pharmacol Ther (2002) 0.98
Simultaneous quantitative measurements of absolute gallbladder storage and emptying during fasting and eating in humans. Gastroenterology (1987) 0.98
Ursodeoxycholic acid in chronic liver disease. Gut (1991) 0.97
Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology (1994) 0.97
Randomized comparison of Nd YAG laser, heater probe, and no endoscopic therapy for bleeding peptic ulcers. Gastroenterology (1990) 0.97
Evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions. Gut (1986) 0.96
Use of a gamma-labeled bile acid (75SeHCAT) as a test of ileal function. Methods of improving accuracy. Gastroenterology (1986) 0.93
Kinetics for the synthetic bile acid 75selenohomocholic acid-taurine in humans: comparison with [14C]taurocholate. Gastroenterology (1988) 0.91
Sensitization to painful distention and abnormal sensory perception in the esophagus. Gastroenterology (1995) 0.91
Effects of acid suppression on microbial flora of upper gut. Dig Dis Sci (1995) 0.90
Which peptic ulcer patients bleed? Gut (1988) 0.88
Hepatic handling of a synthetic gamma-labeled bile acid (75SeHCAT). Gastroenterology (1988) 0.88
Gastro-oesophageal reflux in patients with coronary artery disease: how common is it and does it matter? Eur J Gastroenterol Hepatol (1996) 0.87
Variation in taste of topical lignocaine anaesthesia for gastroscopy. Aliment Pharmacol Ther (1998) 0.87
Assessment of gall-bladder storage function in man. Clin Sci (Lond) (1983) 0.86
Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis. J Hepatol (1995) 0.86
Optimum bile acid treatment for rapid gall stone dissolution. Gut (1992) 0.86
Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet. Dig Dis Sci (1982) 0.86
Direct measurement of first-pass ileal clearance of a bile acid in humans. Gastroenterology (1991) 0.86
Effect of cimetidine on renal function in man. Br J Clin Pharmacol (1981) 0.86
Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones. Gastroenterology (1988) 0.85
Dissolution of gallbladder stones with methyl tert-butyl ether and stone recurrence: a European survey. Dig Dis Sci (1998) 0.85
Increased risk of biliary tract cancer following gastric surgery. Br J Cancer (1988) 0.85
Can a cholesterol-lowering diet cause gallstones? N Engl J Med (1973) 0.85
The impact of direct access endoscopy, Helicobacter pylori near patient testing and acid suppressants on the management of dyspepsia in general practice. Int J Clin Pract (1998) 0.84
Factors affecting gastric mucosal hydrophobicity in man. Scand J Gastroenterol Suppl (1991) 0.84
Biliary secretion of copper in healthy man. Quantitation by an intestinal perfusion technique. Gastroenterology (1977) 0.84
Enprostil, a prostaglandin E2 analogue, in the treatment of gastric ulcer--a multicentre comparison with pirenzepine. Br J Clin Pract (1990) 0.83
Proceedings: Mechanism of action of chenodeoxycholic acid in gallstone dissolution. Gut (1973) 0.83
Haematemesis as an index of blood-loss. Lancet (1971) 0.83
Measurement of the surface hydrophobicity of human gastrointestinal mucosa. Gastroenterology (1989) 0.83
Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group. Eur J Gastroenterol Hepatol (2000) 0.82
Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group. Aliment Pharmacol Ther (2001) 0.82
Oesophageal cancer in gastric surgery patients. Ital J Gastroenterol (1993) 0.82
Diagnostic tests for the stagnant loop syndrome. Gut (1971) 0.81
Expression of trefoil peptides pS2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers. Gut (1995) 0.81
Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet. Gut (1982) 0.81
Progression of Gastric Mucosal Dysplasia of the Postgastrectomy Stomach. Surg Technol Int (2000) 0.81
Mortality from colorectal and breast cancer in gastric-surgery patients. Int J Colorectal Dis (1988) 0.81